(1)
PREVALENCE, CAUSE, AND PRESCRIPTION TREND IN PATIENTS WITH UPPER RESPIRATORY TRACT INFECTIONS AND MEMBRANOUS TONSILLITIS. Int. Res. J. Pharm. 2013, 4 (2), 175-180. https://doi.org/10.56802/g7sd6f49.